In preclinical models, HA-P5 nanoparticles simultaneously suppressed fibroblast growth factor receptor-2 (FGFR2) and androgen receptor (AR) signaling in sebocytes, reduced sebum synthesis, and reversed acne-associated transcriptomic alterations. The gene discussed is FGFR2; the disease is acne.